Laura Melendez-Alafort (Laura Meléndez-Alafort)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 19

Top Venues

Molecules (Basel, Switzerland)

Pharmaceuticals (Basel, Switzerland)

Nanomaterials (Basel, Switzerland)

International journal of molecular sciences

Istituto Oncologico Veneto Istituto di Ricovero e Cura a Carattere Scientifico

University of London (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Istituto Oncologico Veneto Istituto di Ricovero e Cura a Carattere Scientifico Dec 27 2016

Italy

Ricercatore :: SC Immunologia e Diagnostica Molecolare Oncologica

Education History

University of London

United Kingdom

PHD :: Barts and the London, Queen Mary´s School of Medicine and Dentistry

Universidad La Salle

Mexico

BSC

Publications

Guillermina Ferro-Flores, Alejandra Ancira-Cortez, Blanca Ocampo-Garcia, Laura Melendez-Alafort
Molecularly Targeted Lanthanide Nanoparticles for Cancer Theranostic Applications. Nanomaterials (Basel, Switzerland) 14 (3) (2024)
Guillermina Ferro-Flores, Alejandra Ancira-Cortez, Blanca Ocampo-Garcia, Laura Melendez-Alafort
Molecularly Targeted Lanthanide Nanoparticles for Cancer Theranostic Applications. Nanomaterials (Basel, Switzerland) 14 (3) (2024)
Guillermina Ferro-Flores, Alejandra Ancira-Cortez, Blanca Ocampo-Garcia, Laura Melendez-Alafort
Molecularly Targeted Lanthanide Nanoparticles for Cancer Theranostic Applications. Nanomaterials (Basel, Switzerland) 14 (3) (2024)
Cristina Bolzati, Carolina Gobbi, Guillermina Ferro-Flores, Sofia Turato, Blanca Ocampo-Garcia, Debora Carpanese, Cristina Marzano, Barbara Spolaore, Giulio Fracasso, Antonio Rosato, Laura Melendez-Alafort
Development and Characterization of 99m Tc-scFvD2B as a Potential Radiopharmaceutical for SPECT Imaging of Prostate Cancer. International journal of molecular sciences 25 (1) (2023)
Liliana Mou, Lucia De Dominicis, Sara Cisternino, Hanna Skliarova, Matteo Campostrini, Valentino Rigato, Laura De Nardo, Laura Melendez-Alafort, Juan Esposito, Férid Haddad, Gaia Pupillo
Nuclear Cross-Section of Proton-Induced Reactions on Enriched 48 Ti Targets for the Production of Theranostic 47 Sc Radionuclide, 46c Sc, 44m Sc, 44g Sc, 43 Sc, and 48 V. Pharmaceuticals (Basel, Switzerland) 17 (1) (2023)
Cristina Bolzati, Carolina Gobbi, Guillermina Ferro-Flores, Sofia Turato, Blanca Ocampo-Garcia, Debora Carpanese, Cristina Marzano, Barbara Spolaore, Giulio Fracasso, Antonio Rosato, Laura Melendez-Alafort
Development and Characterization of 99m Tc-scFvD2B as a Potential Radiopharmaceutical for SPECT Imaging of Prostate Cancer. International journal of molecular sciences 25 (1) (2023)
Liliana Mou, Lucia De Dominicis, Sara Cisternino, Hanna Skliarova, Matteo Campostrini, Valentino Rigato, Laura De Nardo, Laura Melendez-Alafort, Juan Esposito, Férid Haddad, Gaia Pupillo
Nuclear Cross-Section of Proton-Induced Reactions on Enriched 48 Ti Targets for the Production of Theranostic 47 Sc Radionuclide, 46c Sc, 44m Sc, 44g Sc, 43 Sc, and 48 V. Pharmaceuticals (Basel, Switzerland) 17 (1) (2023)
Liliana Mou, Lucia De Dominicis, Sara Cisternino, Hanna Skliarova, Matteo Campostrini, Valentino Rigato, Laura De Nardo, Laura Melendez-Alafort, Juan Esposito, Férid Haddad, Gaia Pupillo
Nuclear Cross-Section of Proton-Induced Reactions on Enriched 48 Ti Targets for the Production of Theranostic 47 Sc Radionuclide, 46c Sc, 44m Sc, 44g Sc, 43 Sc, and 48 V. Pharmaceuticals (Basel, Switzerland) 17 (1) (2023)
Cristina Bolzati, Carolina Gobbi, Guillermina Ferro-Flores, Sofia Turato, Blanca Ocampo-Garcia, Debora Carpanese, Cristina Marzano, Barbara Spolaore, Giulio Fracasso, Antonio Rosato, Laura Melendez-Alafort
Development and Characterization of 99m Tc-scFvD2B as a Potential Radiopharmaceutical for SPECT Imaging of Prostate Cancer. International journal of molecular sciences 25 (1) (2023)
Diana Trujillo-Benítez, Myrna Luna-Gutiérrez, Guillermina Ferro-Flores, Blanca Ocampo-Garcia, Clara Santos-Cuevas, Gerardo Bravo-Villegas, Enrique Morales-Ávila, Pedro Cruz-Nova, Lorenza Díaz-Nieto, Janice García-Quiroz, Erika Azorín-Vega, Antonio Rosato, Laura Melendez-Alafort
Design, Synthesis and Preclinical Assessment of 99m Tc-iFAP for In Vivo Fibroblast Activation Protein (FAP) Imaging. Molecules (Basel, Switzerland) 27 (1) (2022)
Nicola Salvarese, Debora Carpanese, Laura Melendez-Alafort, Laura De Nardo, Andrea Calderan, Barbara Biondi, Paolo Ruzza, Antonio Rosato, Cristina Bolzati
Impact of Different [Tc(N)PNP]-Scaffolds on the Biological Properties of the Small cRGDfK Peptide: Synthesis, In Vitro and In Vivo Evaluations. Molecules (Basel, Switzerland) 27 (8) (2022)
Sara Brunello, Nicola Salvarese, Debora Carpanese, Carolina Gobbi, Laura Melendez-Alafort, Cristina Bolzati
A Review on the Current State and Future Perspectives of [ 99m Tc]Tc-Housed PSMA-i in Prostate Cancer. Molecules (Basel, Switzerland) 27 (9) (2022)
Tania Hernández-Jiménez, Guillermina Ferro-Flores, Enrique Morales-Ávila, Keila Isaac-Olivé, Blanca Ocampo-Garcia, Liliana Aranda-Lara, Clara Leticia Santos Cuevas, Myrna Luna-Gutiérrez, Laura De Nardo, Antonio Rosato, Laura Melendez-Alafort
225 Ac-rHDL Nanoparticles: A Potential Agent for Targeted Alpha-Particle Therapy of Tumors Overexpressing SR-BI Proteins. Molecules (Basel, Switzerland) 27 (7) (2022)
Amir R Jalilian, Blanca Ocampo-Garcia, Wanvimol Pasanphan, Tamer M Sakr, Laura Melendez-Alafort, Mariano Grasselli, Ademar B Lugão, Hassan Yousefnia, Clelia Dispenza, Siti Mohd Janib, Irfan U Khan, Michał Maurin, Piotr Ulański, Say Chye Joachim Loo, Agnes Safrany, Joao A Osso, Adriano Duatti, Kattesh V Katti
IAEA Contribution to Nanosized Targeted Radiopharmaceuticals for Drug Delivery. Pharmaceutics 14 (5) (2022)
Laura De Nardo, Gaia Pupillo, Liliana Mou, Juan Esposito, Antonio Rosato, Laura Melendez-Alafort
A feasibility study of the therapeutic application of a mixture of 67/64 Cu radioisotopes produced by cyclotrons with proton irradiation. Medical physics 49 (4) (2022)
Anna Dalla Pietà, Debora Carpanese, Antonella Grigoletto, Anna Tosi, Silvia Dalla Santa, Gabriel Kristian Pedersen, Dennis Christensen, Laura Melendez-Alafort, Vito Barbieri, Paola De Benedictis, Gianfranco Pasut, Isabella Monia Montagner, Antonio Rosato
Hyaluronan is a natural and effective immunological adjuvant for protein-based vaccines. Cellular & molecular immunology 18 (5) (2021)
Jordi Borràs, Julie Foster, Roxana Kashani, Laura Melendez-Alafort, Jane Sosabowski, Joan Suades, Ramon Barnadas-Rodríguez
New Bioconjugated Technetium and Rhenium Folates Synthesized by Transmetallation Reaction with Zinc Derivatives. Molecules (Basel, Switzerland) 26 (8) (2021)
Debora Carpanese, Guillermina Ferro-Flores, Blanca Ocampo-Garcia, Clara Santos-Cuevas, Nicola Salvarese, Alessandro Massimo Gianni, Giulio Fracasso, Laura De Nardo, Cristina Bolzati, Antonio Rosato, Laura Melendez-Alafort
Development of 177Lu-scFvD2B as a Potential Immunotheranostic Agent for Tumors Overexpressing the Prostate Specific Membrane Antigen. Scientific reports 10 (1) (2020)
Nicola Salvarese, Davide Carta, Cristina Marzano, Gabriele Gerardi, Laura Melendez-Alafort, Cristina Bolzati
[99mTc][Tc(N)(DASD)(PNP n)]+ (DASD = 1,4-Dioxa-8-azaspiro[4,5]decandithiocarbamate, PNP n = Bisphosphinoamine) for Myocardial Imaging: Synthesis, Pharmacological and Pharmacokinetic Studies. Journal of medicinal chemistry 61 (24) (2018)

Laura Melendez-Alafort.css-eqlu8i{font-size:small;padding-left:4px;} (Laura Meléndez-Alafort)

Publication Activity (10 Years)

Top Topics

Top Venues

Laura Melendez-Alafort (Laura Meléndez-Alafort)